Summary
Patients with advanced and bulky early-stage cancer of the cervix have an unfavourable prognosis, which may be improved by initial neoadjuvant, cytoreductive chemotherapy. In a phase II study, coordinated at the West Midlands CRC Clinical Trials Unit, Birmingham, using ifosfamide (IFX) in combination with cisplatin and bleomycin (BIP) in advanced and recurrent cervical cancer, we demonstrated a response rate of 69%. This regimen produces rapid responses with acceptable toxicity and has potential for use as neoadjuvant therapy prior to radical radiotherapy in patients presenting with advanced and bulky early-stage disease. In an initial pilot study of this approach, 13 of 19 patients (68%) with primary inoperable disease showed significant tumour regression prior to radical local radiotherapy. Interim analysis of the first 66 patients entered into a randomized study evaluating the value of this approach has shown complete clinical tumour resolution after radical radiotherapy in 24/32 patients (75%) treated with up to three cycles of BIP prior to radiotherapy vs 19/34 patients (56%) treated with radiotherapy alone. There was no evidence that neoadjuvant chemotherapy enhances the acute toxic effects of pelvic radiotherapy. This approach has the potential for improving the outlook in patients with poor-prognosis primary disease.
Similar content being viewed by others
References
Benedetti Panici P, Scambia G, Greggi S, DiRoberto P, Baiocchi G, Mancuso S (1988) Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol 71:344–348
Buxton E, Meanwell C, Hilton C, Mould J, Spooner D, Chetiyawardana A, Lateif T, Paterson M, Redman C, Luesley D, Blackledge G (1989) Combination bleomycin, ifosfamide and cisplatin chemotherapy in cervix cancer. J Natl Cancer Inst 81:359–361
Buxton E, Meanwell C, Mould J, Latief T, Chetiyawardana A, Spooner D, Tobias J, Sokal M, Alcock C, Hilton C, Paterson M, Luesley D, Lawton F, Redman C, Blackledge G (1989) Phase II studies of bleomycin, ifosfamide and cisplatinum in cervix cancer. Acta Oncol 27:545–549
Chauvergne J, Rohart J, Heron J, Fargeot P, Berlie J, David P, George M (1988) Randomised phase III trial of neoadjuvant chemotherapy plus radiotherapy versus radiotherapy in stage IIb, III carcinoma of the cervix: a cooperative study of the French oncology centers. Proc Am Soc Clin Oncol 7:136, abstr. 524
Dixon W, Brown M, Engelman L, Frane J, Hill M, Jennrich R, Toporek J (1985) BMDP statistical software manual, 5th edn. University of California Press, Berkeley
Friedlander M, Kaye S, Sullivan A, Green D, Houghton R, Solomon H, Russell P, Tattersall M (1983) Cervical carcinoma: a drug-responsive tumour-experience with combined cisplatin, vinblastine and bleomycin therapy. Gynecol Oncol 16:275–281
Kirsten F, Atkinson K, Coppleson J, Elliott P, Green D, Houghton R, Murray J, Russell P, Solomon H, Friedlander M, Swanson C, Tattersall M (1987) Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynaecol 94:583–588
Meanwell C, Blake E, Kelly K, Honigsberger L, Blackledge G (1986) Prediction of ifosfamide/mesna associated encephalopathy. Eur J Cancer Clin Oncol 22:815–819
Miller A, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214
Morgan L, Nelson J (1982) Surgical treatment of early cervical cancer. Semin Oncol 9:312–330
Piver M, Barlow J (1977) High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix. Cancer 39:1243–1246
Souhami L, Gil R, Allan S (1988) Randomized trial of neoadjuvant chemotherapy followed by pelvic radiotherapy versus radiotherapy alone in stage IIIb carcinoma of the cervix. Proc Am Soc Clin Oncol 7: 139, abstr. 538
Symonds R, Watson E, Habeshaw T, Kaye S (1987) Chemotherapy prior to radical radiotherapy for stage III and IV carcinoma of the cervix. Clin Radio 38: 273–274
Thar T, Million R, Daly J (1982) Radiation treatment of carcinoma of the cervix. Semin Oncol 9:299–311
Vermorken J, Mangioni C, Oosterom A van, Pecorelli C, Burg M van den, Ten Bokkel Huinink W, Dalesio O, Rotmenmsz N (1983) Vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in squamous cell carcinoma of the uterine cervix (SCCUC). Proceedings, 2nd European Conference on Clinical Oncology, Amsterdam, p 50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tobias, J., Buxton, E.J., Blackledge, G. et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother. Pharmacol. 26 (Suppl 1), S59–S62 (1990). https://doi.org/10.1007/BF00685422
Issue Date:
DOI: https://doi.org/10.1007/BF00685422